New Foreign Investment Rules in Indonesia’s Healthcare and Pharmaceutical Sectors

The New Investment List contained in Presidential Regulation No. 10 of 2021 regarding Investment Sectors (the New Investment List) contains significant changes to foreign direct investment (FDI) in Indonesia. These changes were foreshadowed by the enactment in November 2020 of Law No. 11 of 2020 regarding Job Creation (the Omnibus Law), and include liberalisation of certain aspects of the healthcare and pharmaceutical sectors.

We present our observations on the key FDI changes under the New Investment List for businesses operating in Indonesia’s healthcare and pharmaceutical sectors. Continue reading

Foreign Investment in Indonesia’s Consumer Sector: Many Distribution, Retail and Logistics Businesses Liberalised

The new investment list under Presidential Regulation No. 10 of 2021 regarding Investment Sectors (the New Investment List), which sets out new foreign investment restrictions for a raft of sectors in Indonesia, has replaced the former negative list under Presidential Regulation No. 44 of 2016 (the 2016 Negative List) since 4 March 2021. Continue reading

Indonesia’s New Investment List: Liberalisation of Foreign Investment in the Energy, Resources and Infrastructure Sectors

The Indonesian government has published its long-awaited new investment list, under Presidential Regulation No. 10 of 2021 regarding Investment Sectors (the New Investment List), which sets out important new foreign investment rules for a raft of sectors in Indonesia. It will replace Presidential Regulation No. 44 of 2016 (known as the 2016 Negative List) when the New Investment List takes effect on 4 March 2021. Continue reading